Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransUnion (TRU) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for TransUnion (TRU) over the last 15 years, with Q3 2025 value amounting to $749.9 million.

  • TransUnion's Cash & Equivalents rose 1658.89% to $749.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $749.9 million, marking a year-over-year increase of 1658.89%. This contributed to the annual value of $679.5 million for FY2024, which is 4269.21% up from last year.
  • Latest data reveals that TransUnion reported Cash & Equivalents of $749.9 million as of Q3 2025, which was up 1658.89% from $687.5 million recorded in Q2 2025.
  • TransUnion's 5-year Cash & Equivalents high stood at $1.8 billion for Q4 2021, and its period low was $420.9 million during Q3 2023.
  • Its 5-year average for Cash & Equivalents is $665.0 million, with a median of $585.3 million in 2022.
  • In the last 5 years, TransUnion's Cash & Equivalents skyrocketed by 27393.95% in 2021 and then plummeted by 6823.17% in 2022.
  • Quarter analysis of 5 years shows TransUnion's Cash & Equivalents stood at $1.8 billion in 2021, then plummeted by 68.23% to $585.3 million in 2022, then fell by 18.64% to $476.2 million in 2023, then surged by 42.69% to $679.5 million in 2024, then grew by 10.36% to $749.9 million in 2025.
  • Its Cash & Equivalents stands at $749.9 million for Q3 2025, versus $687.5 million for Q2 2025 and $609.9 million for Q1 2025.